0001567619-21-013527.txt : 20210715 0001567619-21-013527.hdr.sgml : 20210715 20210715200545 ACCESSION NUMBER: 0001567619-21-013527 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210713 FILED AS OF DATE: 20210715 DATE AS OF CHANGE: 20210715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reinhart Harald CENTRAL INDEX KEY: 0001835824 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38205 FILM NUMBER: 211093869 MAIL ADDRESS: STREET 1: 4560 JINKE ROAD, BLDG. 1, FOURTH FLOOR STREET 2: PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zai Lab Ltd CENTRAL INDEX KEY: 0001704292 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 BUSINESS PHONE: 862161632588 MAIL ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 4 1 doc1.xml FORM 4 X0306 4 2021-07-13 0 0001704292 Zai Lab Ltd ZLAB 0001835824 Reinhart Harald C/O ZAI LAB LIMITED 4560 JINKE ROAD, BLDG 1, 4TH FLOOR PUDONG, SHANGHAI F4 201210 CHINA 0 1 0 0 Chief Medical Officer Ordinary Shares 2021-07-13 4 M 0 8000 18.00 A 8000 D Ordinary Shares 2021-07-13 4 S 0 8000 169.92 D 0 D Ordinary Shares 2021-07-14 4 M 0 4000 18.00 A 4000 D Ordinary Shares 2021-07-14 4 S 0 4000 169.11 D 0 D Ordinary Shares 2021-07-14 4 M 0 4000 17.99 A 4000 D Ordinary Shares 2021-07-14 4 S 0 4000 169.11 D 0 D Stock Options (Right to Buy) 18.00 2021-07-13 4 M 0 8000 0.00 D 2027-09-20 Ordinary Shares 8000 44000 D Stock Options (Right to Buy) 18.00 2021-07-14 4 M 0 4000 0.00 D 2027-09-20 Ordinary Shares 4000 40000 D Stock Options (Right to Buy) 17.99 2021-07-14 4 M 0 4000 0.00 D 2028-11-16 Ordinary Shares 4000 46000 D The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The options vest in equal annual installments over five years beginning on 09/20/2018, the first anniversary of the date of grant. The options vest in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant. /s/ Bruce A. Blefeld, Attorney-in-Fact 2021-07-15